Liposomes complexed to plasmids encoding angiostatin and endostatin inhibit breast cancer in nude mice

Cancer Research

Volumn 59, Issue 14, 1999, Pages 3308-3312

  Chen, Qing Rong ^a   Kumar, Dhruv ^b   Stass, Sanford A ^a   Mixson, A James ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b SINAI HOSPITAL OF BALTIMORE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; ANGIOSTATIN; ENDOSTATIN; LIPOSOME; MATRIGEL;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CANCER; GENE AMPLIFICATION; GENE THERAPY; MAMMARY GLAND FUNCTION; NONHUMAN; NUDE MOUSE; PLASMID; PRIORITY JOURNAL; TREATMENT PLANNING; TUMOR GROWTH; TUMOR VOLUME;

ANGIOSTATINS; ANIMALS; BREAST NEOPLASMS; CATIONS; COLLAGEN; CULTURE MEDIA, CONDITIONED; DRUG CARRIERS; DRUG COMBINATIONS; ENDOSTATINS; FEMALE; GENE THERAPY; GENETIC VECTORS; HUMANS; INJECTIONS, INTRALESIONAL; LAMININ; LIPOSOMES; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; PEPTIDE FRAGMENTS; PLASMINOGEN; PROTEOGLYCANS; TUMOR CELLS, CULTURED;

EID: 0033565645     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Folkman, J. Antiangiogenic therapy. In: V. T. DeVita, Jr., S. Hellman, and S. A. Rosenberg (eds.), Cancer: Principles & Practice of Oncology, pp. 3075-3085. Philadelphia: Lippincott-Raven, 1997.
2. O'Reilly, M. S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R. A., Moses, M., Lane, W. S., Cao, Y., Sage, E. H., and Folkman, J. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma. Cell, 79: 315-328, 1994
3. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88: 277-285, 1997.
4. O'Reilly, M. S., Holmgren, L., Chen, C., and Folkman, J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat. Med., 2: 689-692, 1996
5. Cao, Y., O'Reilly, M. S., Marshall, B., Flynn, E., Ji, R. W., and Folkman, J. Expression of angiostatin cDNA in a murine fibrosarcoma suppresses primary tumor growth and produces long-term dormancy of metastases. J. Clin. Investig., 101: 1055-1063, 1998.
6. Folkman, J. Antiangiogenic gene therapy. Proc. Natl. Acad. Sci. USA, 95: 9064-9066, 1998.
7. Tanaka, T., Cao, Y., Folkman, J., and Fine, H. A. Viral vector-targeted antiangiogenic gene therapy utilizing angiostatin complementary DNA. Cancer Res., 58: 3362-3369, 1998.
8. Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., Thoma, K. A., and Curiel, D. T. Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate. Proc. Natl. Acad. Sci. USA, 95: 8795-8800, 1998.
9. Lin, P., Buxton, J. A., Acheson, A., Radziejewski, C., Maisonpierre, P. C., Yancopoulos, G. D., Channon, K. M., Hale, L. P., Dewhirst, M. W., George, S. E., and Peters, K. G. Antiangiogenic gene therapy targeting the endothelium-specific receptor tyrosine kinase Tie2. Proc. Natl. Acad. Sci. USA, 95: 8829-8834, 1998.
10. Griscelli, F., Li, H., Griscelli, A. B., Soria, J., Opolon, P., Soria, C., Perricaudet, M., Yeh, P., and Lu, H. Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest. Proc. Natl. Acad. Sci. USA, 95: 6367-6372, 1998.
11. Kong, H. L., Hecht, D., Song, W., Kovesdi, I., Hachett, N. R., Yayon, A., and Crystal, R. G. Regional suppression of tumor growth by in vivo transfer of a cDNA encoding secreted form of the extracellular domain of the flt-1 vascular endothelial growth factor receptor. Hum. Gene Ther., 9: 823-833, 1998.
12. Lesson-Wood, L. A., Kim, W. H., Kleinman, H. K., Weintraub, B. D., and Mixson, A. J. Systemic gene therapy with p53 reduces growth and metastases of a malignant human breast cancer in nude mice. Hum. Gene Ther., 6: 395-405, 1995.
13. Nabel, E. G., Gordon, D., Yang, Z. H., Xu, L., San, H., Plautz, G. E., Wu, B. Y., Juang, L., and Nabel, G. J. Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Hum. Gene Ther., 3: 649-656, 1992.
14. Stewart, M. J., Plautz, G. E., Buono, L. D., Yang, Z. Y., Xu, L., Gao, X., Huang, L., Nabel, E. G., and Nabel, G. J. Gene transfer in vivo with DNA-liposome complexes: safety and acute toxicity in mice. Hum. Gene Ther., 3: 267-275, 1992.
15. Xu, M., Kumar, D., Srinivas, S., Detolla, L. J., Yu, S. F., Stass, S. A., and Mixson, A. J. Parenteral gene therapy with p53 inhibits human breast tumors in vivo through a bystander mechanism without evidence of toxicity. Hum. Gene Ther., 8: 177-185, 1997.
16. Sargent, T. D., Yang, M., and Bonner, J. Nucleotide sequence of cloned rat serum albumin messenger RNA. Proc. Natl. Acad. Sci. USA, 78: 243-246, 1981.
17. Passaniti, A., Taylor, R. M., Pili, R., Guo, Y., Long, P. V., Haney, J. A., Pauly, R. R., Grant, D. S., and Martin, G. R. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. Lab. Investig., 67: 519-528, 1992.
18. Thurston, G., McLean, J. W., Rizen, B., Haskel, A., Murphy, T. J., Hanahan, D., and McDonald, D. M. Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice. J. Clin. Investig., 101: 1410-1413, 1998.
19. Arap, W., Pasqualini, R., and Ruoslahti, E. Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model. Science (Washington DC), 279: 377-381, 1998.